Galecto

3 followers


Galecto is a clinical-stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.

Industries

Employees

11-50

Links

Org chart

Hans T. Schambye
President & CEO

Hans T. Schambye

Collapse
Tariq Sethi
Co-Founder
Garrett Winslow
General Counsel, Corporate Secretarty
Frank L.
Global SVP (China medical information public opinion security)
Rob Slack, FRSB
Vice President & Head of Pharmacology
Becky Smith
Interim Project Leader
Zahir Rajiwate
Director, Clinical Operations & Data Management